Literature DB >> 19891937

Bisphosphonate therapy: when not to monitor BMD.

Umang Sharma1, James J Stevermer.   

Abstract

Entities:  

Year:  2009        PMID： 19891937      PMCID： PMC3183920     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


× No keyword cloud information.
  8 in total

1.  American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.

Authors:  Stephen F Hodgson; Nelson B Watts; John P Bilezikian; Bart L Clarke; T Kenney Gray; David W Harris; C Conrad Johnston; Michael Kleerekoper; Robert Lindsay; Marjorie M Luckey; Michael R McClung; Howard R Nankin; Steven M Petak; Robert R Recker
Journal:  Endocr Pract       Date:  2003 Nov-Dec       Impact factor: 3.443

2.  An estimate of the worldwide prevalence and disability associated with osteoporotic fractures.

Authors:  O Johnell; J A Kanis
Journal:  Osteoporos Int       Date:  2006-09-16       Impact factor: 4.507

3.  Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group.

Authors:  S R Cummings; L Palermo; W Browner; R Marcus; R Wallace; J Pearson; T Blackwell; S Eckert; D Black
Journal:  JAMA       Date:  2000-03-08       Impact factor: 56.272

4.  Management of postmenopausal osteoporosis: position statement of the North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2002 Mar-Apr       Impact factor: 2.953

5.  Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.

Authors:  S R Cummings; D M Black; D E Thompson; W B Applegate; E Barrett-Connor; T A Musliner; L Palermo; R Prineas; S M Rubin; J C Scott; T Vogt; R Wallace; A J Yates; A Z LaCroix
Journal:  JAMA       Date:  1998 Dec 23-30       Impact factor: 56.272

6.  Cost effectiveness of screen-and-treat strategies for low bone mineral density: how do we screen, who do we screen and who do we treat?

Authors:  John T Schousboe
Journal:  Appl Health Econ Health Policy       Date:  2008       Impact factor: 2.561

7.  Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis.

Authors:  Catherine MacLean; Sydne Newberry; Margaret Maglione; Maureen McMahon; Veena Ranganath; Marika Suttorp; Walter Mojica; Martha Timmer; Alicia Alexander; Melissa McNamara; Sheetal B Desai; Annie Zhou; Susan Chen; Jason Carter; Carlo Tringale; Di Valentine; Breanne Johnsen; Jennifer Grossman
Journal:  Ann Intern Med       Date:  2007-12-17       Impact factor: 25.391

8.  Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data.

Authors:  Katy J L Bell; Andrew Hayen; Petra Macaskill; Les Irwig; Jonathan C Craig; Kristine Ensrud; Douglas C Bauer
Journal:  BMJ       Date:  2009-06-23
  8 in total
  1 in total

Review 1.  Botanicals and Their Bioactive Phytochemicals for Women's Health.

Authors:  Birgit M Dietz; Atieh Hajirahimkhan; Tareisha L Dunlap; Judy L Bolton
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.